Condition

Glaucoma and Ocular Hypertension

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 14 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials14

Recruiting1

Common interventions22

Lead sponsors shown11

Clinical trials

14 shown

Clarifying the Optimal Application of SLT Therapy TrialNCT04967989 · 2021-09-07

24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP MonitoringNCT06689696 · 2025-02-19

Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma PatientsNCT05181046 · 2021-11-06

Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo)NCT04337944 · 2020-04-08

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 StudyNCT03691662 · 2018-09-27

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 StudyNCT03691649 · 2018-09-14

Effect of Dexamethasone Implant on Optic DiscNCT03927118 · 2018-02-01

Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled GlaucomaNCT03187418 · 2017-06-19

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle GlaucomaNCT02371746 · 2015-01-01

Prospective,Randomized,Controlled Study to Assess Efficacy,Safety, and Tolerability of SLT vs. PLT in Patients With POAGNCT02231515 · 2014-04-01

Combined Ex-PRESS Implantation Alone or With Phacoemulsification for Glaucoma Associated With CataractNCT02209961 · 2014-03-01

Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular HypertensionNCT01687426 · 2012-09-01

A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHTNCT01654484 · 2012-07-01

Artificial Intelligence for Staging Glaucoma Severity: A Comparison With an Eye Specialist Using Visual Field TestsNCT07820709 · 2011-04-15

Common interventions

Leading sponsors

Santen Inc.3 Centre hospitalier de l'Université de Montréal (CHUM)2 Bulent Ecevit University1 Envisia Therapeutics1 Eye Therapies, LLC1 Hillel Yaffe Medical Center1 Nanodropper, Inc.1 Smartlens, Inc.1 University Hospital, Geneva1 University of Pittsburgh1 University of Salerno1

Trial status mix

COMPLETED10

UNKNOWN2

RECRUITING1

TERMINATED1

Phase mix

NA4

PHASE33

PHASE12

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.